alemtuzumab   Click here for help

GtoPdb Ligand ID: 6770

Synonyms: campath 1H | Campath® | campath-1H | Lemtrada®
Approved drug Immunopharmacology Ligand
alemtuzumab is an approved drug (FDA (2001), EMA (2013))
Compound class: Antibody
Comment: CAMPATH-1 (CD52) antigen inhibitor. Functionally, alemtuzumab causes depletion and then recovery of the immune system.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: alemtuzumab

Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2001), EMA (2013))
International Nonproprietary Names Click here for help
INN number INN
8005 alemtuzumab
Synonyms Click here for help
campath 1H | Campath® | campath-1H | Lemtrada®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 11
Other databases
GtoPdb PubChem SID 178103376
PubChem SID 178103376
Search PubMed clinical trials alemtuzumab
Search PubMed titles alemtuzumab
Search PubMed titles/abstracts alemtuzumab
Wikipedia Alemtuzumab